MetLife, Inc. (MET) fair value analysis
S&P 500 · Updated 2026-10-19
MET price how computed
Forward Fair Value verdict
Fairly valuedMET is trading at within about 10% of estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $98.33
- Sector
- Financial Services
- 12-month range
- $67.70–$100.76
- Market cap
- $62.5B
- From 52-week high
- -2.4%
- Shares outstanding
- 635M
- Rank in Financial Services by discount to fair value
- #88 of 167
Last price is our 2026-10-19 weekly price; the chart runs through 2026-10-16.
MetLife, Inc. is a leading global insurance company that provides life insurance, annuities, employee benefits, and other financial services to individuals and institutional clients. The company operates across the United States and numerous international markets worldwide.
MET currently ranks #88 of 167 Financial Services stocks by discount to fair value. It has screened as Fairly valued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $62.5B
- P/E (trailing)
- 10x
- Revenue (TTM)
- $78.6B
- Net margin
- 4.6%
- EPS (TTM)
- $9.68
- Gross margin
- 14.8%
- Debt / equity
- 0.74
- Revenue growth (3-yr avg)
- 6.3%
- Shares outstanding
- 635M
Derived indicators how computed
- Quality grade
- C
- Margin trend
- Contracting
- 52-week position
- The top quarter of its range
Technicals how computed
- RSI (14-day)
- 61 · neutral
- 50-day average
- $96.87
- 200-day average
- $84.63
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Dividends how computed
- Paid, last 12 months
- $2.32 per share (4 payments)
- Yield on last price
- 2.36%
- Consecutive years of increases
- 7
- Next ex-dividend date
- 2026-11-03
- Last payment date
- 2026-09-08
Earnings how computed
- Next earnings report
- 2026-11-04 (post-market)
- Last 8 quarters vs consensus
- 4 beat, 3 missed
- Quarter by quarter
- 2026-06 ▲ beat (+5.7%)
2026-03 ▲ beat (+6.6%)
2025-12 ▲ beat (+6.4%)
2025-09 ▲ beat (+0.4%)
2025-06 ▼ miss (-6.5%)
2025-03 ▼ miss (-2.5%)
2024-12 ▬ met (0.0%)
2024-09 ▼ miss (-10.6%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 13 buy · 4 hold · 1 sell (18 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $107
- Target vs last price
- +8.8%
What our data shows for MET
- Our model validated 17 trailing price-to-earnings windows for MET, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $67.70–$100.76.
- The 14-day relative strength index sits at a neutral 61.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MET
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent MET news
TickrTrends' derived news-sentiment signal for MET is currently leaning positive, computed from recent coverage.
- MET Maintained by Wells Fargo -- Price Target Raised to $110 (gurufocus.com, 2026-10-12)
TickrTrends take: Wells Fargo's decision to raise its price target for MET to $110 while maintaining its rating suggests the analyst sees value at current levels without signaling a shift to a more bullish stance. Given TickrTrends' assessment that MET is fairly valued, this price target adjustment represents a modest update to consensus expectations rather than a fundamental revaluation. Investors focused on valuation metrics should monitor whether MET's fundamentals continue to support this elevated price target or whether market conditions in the Financial Services sector create divergence between analyst expectations and intrinsic value. - MET Maintains Buy Rating by TD Cowen -- Price Target Raised to $110 (gurufocus.com, 2026-10-05)
TickrTrends take: TD Cowen's decision to raise its price target for MET to $110 while maintaining a buy rating suggests analyst confidence in the company's financial prospects within the Financial Services sector. Given TickrTrends' current assessment that MET is fairly valued, the raised price target indicates potential upside if the company executes according to analyst expectations. A valuation-focused reader should monitor whether MET's fundamentals and earnings trajectory support closing any gap between current pricing and the $110 target, as this would help validate whether the fairly valued designation holds or shifts. - New York Giants at NYSE for 40th Anniv. of Super Bowl XXI: NYSE Content Update (prnewswire.com, 2026-10-02)
TickrTrends take: MET's Fairly valued designation by TickrTrends reflects balanced pricing relative to the Financial Services sector, providing a neutral foundation as the company maintains its market presence through various corporate activities and sponsorships. The Giants' appearance at the NYSE marks a cultural milestone that underscores the visibility and brand association opportunities available to major financial institutions based in New York. Investors tracking MET should continue monitoring whether such high-profile engagements contribute meaningfully to business fundamentals or primarily serve brand reinforcement purposes.
What people are saying
Follow the MET conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — MET's sector discount rank improved this week, moving from number 90 to number 85 among Financial Services companies. The stock maintains a fairly valued assessment according to current valuation metrics. This improvement in relative valuation positioning suggests MET has become slightly more attractively priced within its sector peer group.
- 2026-10-06 — # MET Weekly Indicator Summary TickrTrends' derived indicators for MET showed movement this week as the company's sector discount rank improved from #98 to #90 within the Financial Services sector. The stock maintains a current valuation verdict of Fairly valued. This ranking shift reflects a modest improvement in MET's relative valuation position compared to other companies in its sector.
- 2026-09-28 — TickrTrends' derived indicators for MET show that the stock's sector discount rank declined from #78 to #83 this week, indicating a relative weakening in its valuation position within the Financial Services sector. Despite this shift, MET maintains a current valuation verdict of fairly valued.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is MET stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), MET is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is MET's TickrTrends verdict?
MET's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does MET compare to other Financial Services stocks?
MET ranks #88 of 167 Financial Services stocks in TickrTrends' coverage by discount to fair value.
Is MET overbought or oversold?
MET's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does MET pay a dividend?
Yes. MET paid $2.32 per share over the last twelve months (4 payments), a 2.36% yield on TickrTrends' last price, and has raised the annual total for 7 consecutive years. The next ex-dividend date on file is 2026-11-03.
When does MET report earnings next?
MET's next earnings report is scheduled for 2026-11-04 (post-market), per the published earnings calendar.
Does MET usually beat earnings estimates?
Over its last 8 reported quarters MET beat the consensus estimate 4 times and missed 3 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about MET?
Of 18 analysts covering MET, 13 rate it a buy, 4 a hold and 1 a sell - buy-leaning, with a consensus price target of $107 (+8.8% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Financial Services
Head-to-head comparisons
MET vs AIZ · MET vs BHF · MET vs CME · MET vs COLB · MET vs GL